<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0210353.ref037">
 <label>37</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Cordero</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Rodríguez</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Batalla</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>López</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Torres</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Castellano</surname>
   <given-names>JM</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: results from the CAPS study</article-title>. 
  <source>Cardiovasc Ther</source>
  <year>2017</year>; 
  <volume>35</volume>: 
  <fpage>e12240</fpage>.
 </mixed-citation>
</ref>
